Resources

Cognito Therapeutics Announces Spectris™ Demonstrates Durable Effects on Activities of Daily Living in the OVERTURE II Study

Cognito Therapeutics Announces Spectris™ OVERTURE OLE Study Data Supports Potential Disease Modification and Early Treatment in Alzheimer’s Disease

Cognito Therapeutics OVERTURE Clinical Trial in Alzheimer's Disease Published in Frontiers in Neurology

A New Headset Aims to Treat Alzheimer’s With Light and Sound

Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer’s disease

Cognito Therapeutics Announces Oral Presentation on Spectris™ Therapy Open-Label Study Data in Alzheimer’s Disease at AD/PD 2024